Skip to main content

ITeos Therapeutics

Cambridge, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

May 2024
Post-IPO Equity

Top Investors

RA Capital ManagementJanus Henderson InvestorsRTW InvestmentsInvusMPM Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ITeos Therapeutics

Who are ITeos Therapeutics's investors?
ITeos Therapeutics's investors include RA Capital Management, Janus Henderson Investors, RTW Investments, Invus, MPM Capital.
Where is ITeos Therapeutics headquartered?
ITeos Therapeutics is headquartered in Cambridge, United States.
What does ITeos Therapeutics do?
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
What stage is ITeos Therapeutics at?
ITeos Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ITeos Therapeutics — Funding & Investors." VCBacked, May 10, 2024, https://www.vcbacked.co/company/iteos-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2024). ITeos Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/iteos-therapeutics
Wikipedia (cite web)
{{cite web |title=ITeos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iteos-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .